Related Experiment Video

Updated: Feb 14, 2026

An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

9.4K

OPA1: How much do we know to approach therapy?

Valentina Del Dotto1, Mario Fogazza2, Guy Lenaers3

  • 1Unit of Neurology, Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Pharmacological Research
|February 19, 2018
PubMed

Insights

Opa1 protein is crucial for mitochondrial health and function. Mutations in OPA1 cause dominant optic atrophy and other neurodegenerative diseases, highlighting the need for new therapeutic strategies.

Area of Science:

  • Mitochondrial biology
  • Neurogenetics

Background:

  • Opa1 (Optic Atrophy 1) is a GTPase regulating mitochondrial dynamics, energetics, mtDNA maintenance, and cristae integrity.
  • Recent discoveries reveal additional cellular roles and interactions of Opa1.
  • Opa1 dysfunction is linked to dominant optic atrophy (DOA) and various neurodegenerative disorders.

Purpose of the Study:

  • To review recent findings on Opa1 protein functions.
  • To elucidate the pathogenic mechanisms of Opa1 mutations.
  • To discuss therapeutic options and future perspectives for Opa1-related disorders.

Main Methods:

  • Literature review of recent studies on Opa1.
  • Analysis of molecular functions and cellular pathways involving Opa1.
  • Correlation of Opa1 dysfunction with clinical phenotypes and disease progression.

Main Results:

  • Opa1 plays a central role in maintaining mitochondrial structure and function.
  • Opa1 mutations are implicated in the pathogenesis of dominant optic atrophy and other neurodegenerative conditions.
  • Understanding Opa1's multifaceted roles is key to developing targeted therapies.

Conclusions:

  • Opa1 is essential for neuronal health, and its mutations lead to significant neurological deficits.
  • Further research into Opa1's functions and interactions is critical for advancing treatment strategies.
  • Targeting Opa1 pathways offers promising therapeutic avenues for dominant optic atrophy and related neurodegenerative diseases.
Keywords:
DOA therapyDominant optic atrophyMitochondria dynamicsOPA1 mutations

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.2K
Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal07:24

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

Published on: September 12, 2025

535

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
472
Frustration and Conflict: Approach-Approach, Approach-Avoidance01:20

Frustration and Conflict: Approach-Approach, Approach-Avoidance

Frustration occurs when people are obstructed or prevented from achieving a desired goal or fulfilling a perceived need. For example, when someone's input is ignored in a discussion, it can lead to feelings of frustration. Conflict, however, arises from opposing interests, goals, or actions. Conflicts can take various forms based on the nature of these opposing desires or goals.
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
553
Behavior Therapy01:22

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
752
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
310
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.3K